BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 4, 2006
View Archived Issues
Lipid Sciences files IDE for Plasma Delipidation System-2
Read More
Private placement funds to support phase II Reolysin development
Read More
Zydus Cadila files IND for antiinflammatory compound ZYI-1
Read More
Samaritan initiates new phase IIb for SP-01A in HIV
Read More
Positive results from synDNA hepatitis B study
Read More
InSite Vision completes debt refinancing to support AzaSite development and filing
Read More
Recordati signs agreement with Osmotica for modified-release lercanidipine
Read More
sNDA submission for Seroquel in bipolar depression
Read More
Cerus files IND for phase I study of CRS-100
Read More
New designer antibacterial agents from Rib-X Pharmaceuticals
Read More
MBX-037 demonstrates antibacterial potential of DNA polymerase IIIC inhibitors
Read More
New agents with activity against HIV reported in patent literature
Read More
New agents and strategies for respiratory disorders
Read More
Cervical cancer vaccine induces greater response in younger women
Read More
Inhaled aztreonam reduces P. aeruginosa in cystic fibrosis patients
Read More
NDA submission for telbivudine in chronic hepatitis B
Read More
U.S. launch for Increlex
Read More
Symadex studied in metastatic breast cancer
Read More
KRX-0401 studied in new phase II trial for multiple myeloma
Read More
Selective targeting of the immunoproteasome for hematologic malignancies
Read More
Nonapprovable letter for Cesamet labeling changes
Read More
AZD-2479 for dyslipidemia begins phase I study
Read More
Studies reveal antibiotic activity of CSA-13
Read More